SecBot SecBot
SC 13G/A ·Filed Nov 6, 2026

QGEN

QIAGEN N.V.
NEUTRAL
Impact 2/10
Horizonimmediate Processed10d 17h ago SEC0000902219-26-000322
Passive stake amendment
Actionable Insight • Neutral

The reduction is minor and consistent with passive portfolio adjustments. No further action warranted; monitor for any future 13D conversion or material change in position.

DirectionNeutral
Confidencehigh
Horizonimmediate

How the stock moved after the report

⚠ Clustered NEUTRAL VIEWSTOCK BELOW ENTRY AT T+5
Entry
$50.33
T+0 close · Nov 6, 2026 · via day close
Latest settled
−0.87%
T+5 · $49.89
Vs SPY
−3.47%
α at T+5
Next horizon
T+20
in 20d
  1. T+0 · Nov 6 $50.33entry
  2. T+1 · 8d ago +0.44%α −1.93% · $50.55
  3. T+5 · 4d ago −0.87%α −3.47% · $49.89
  4. T+6 · todayOpen
  5. T+20 · in 20d Pending
  6. T+60 · in 3mo Pending

Price Chart

Loading chart...

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

Wellington Management Group LLP filed an amended Schedule 13G disclosing a 0.9% passive stake in Qiagen N.V. as of October 30, 2026, down from the prior filing's 1.0% stake. The reduction is routine portfolio rebalancing by a passive institutional holder and carries no material directional signal.

Key Financial Metrics

Stake
0.9%
Investor
Wellington Management Group LLP

Key Facts

  • Wellington Management Group LLP reported beneficial ownership of 1,869,523 common shares of Qiagen N.V.
  • The stake represents 0.9% of shares outstanding as of October 30, 2026.
  • The prior 13G/A (filed June 5, 2026) showed a 1.0% stake, indicating a slight reduction.
  • Wellington is a passive institutional investor filing under Rule 13d-1(b).
  • The filing includes a joint filing agreement among Wellington Management Group LLP, Wellington Group Holdings LLP, and Wellington Investment Advisors Holdings LLP.

Financial Impact

Stake reduced from approximately 1.0% to 0.9% of shares outstanding; no dollar value stated.

ownership_percentage

Risk Factors

  • Further selling by Wellington could signal reduced institutional confidence.
  • Passive 13G filers may convert to 13D if they become activist, but no indication here.

Market Snapshot

Exchange
NYSE
Sector
Biological Products, (No Diagnostic Substances)
Analyst Consensus
38% bullish (21 analysts)

Investment Themes

Documents Analyzed

This report is based on 3 SEC documents filed with EDGAR.

DocumentAccession Number
SC 13G/A Filing (Primary)0000902219-26-000322
Document: 0000902219-26-000322-index.html0000902219-26-000322
Document: 0000902219-26-000322.txt0000902219-26-000322

Track record

7 reports on QGEN

Performance horizon

3 of 4 bullish or bearish reports moved the stock their way by T+5. Best: +0.99% at T+5 after the Oct 27, 2026 report. 3 of 4 went positive at some point.

Filters
  1. Nov 6, 202610d ago SC 13G/A Neutral 2/10 Viewing Entry $50.33 to $49.89 Now $49.81 −1.03% ▼ −0.87% −3.47% vs SPY
  2. Nov 5, 202611d ago 6-K Bearish 6/10 Entry $50.33 to $49.89 Now $49.81 +1.03% ▲ +0.87% +3.47% vs SPY
  3. Nov 5, 202611d ago 6-K Neutral 5/10 No price data
  4. Nov 4, 202612d ago Institutional Cluster Mixed 3/10 Entry $50.86 to $50.10 Now $49.81 −2.06% ▼ −1.49% −4.78% vs SPY
  5. Oct 27, 202620d ago SC TO-C Bullish 7/10 Entry $50.33 to $50.83 Now $49.81 −1.03% ▲ +0.99% +1.71% vs SPY
  6. Oct 23, 202624d ago 6-K Bullish 8/10 Entry $50.39 to $50.22 Now $49.81 −1.15% ▼ −0.34% +0.22% vs SPY
  7. Oct 22, 202625d ago SC TO-C Bullish 8/10 Entry $50.22 to $50.34 Now $49.81 −0.82% ▲ +0.24% −0.47% vs SPY
Showing 7 of 7

US Market Status

Market Closed · Opens in 7h 22m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Nov 6, 2026